Predictive value of interatrial block on electrocardiogram among obese patients undergoing atrial fibrillation ablation.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 12 07 2022
accepted: 24 11 2022
medline: 28 8 2023
pubmed: 4 12 2022
entrez: 3 12 2022
Statut: ppublish

Résumé

Determine a predictive value of interatrial block (IAB) on atrial fibrillation (AF) ablation outcomes in obese patients. Medical records were retrospectively reviewed for 205 consecutive patients with body mass indices (BMI) ≥ 30 kg/m The mean BMI was 36.9 ± 5.7 kg/m IAB is highly prevalent in patients with obesity and AF. Partial IAB, defined as PWD ≥ 120 ms, and advanced IAB with evidence of biphasic P-wave in inferior leads were independently associated with increased risk of recurrent arrhythmia after AF ablation. Its predictive value is independent of other traditional risk factors, LAVI, or use of AADs.

Sections du résumé

BACKGROUND BACKGROUND
Determine a predictive value of interatrial block (IAB) on atrial fibrillation (AF) ablation outcomes in obese patients.
METHODS METHODS
Medical records were retrospectively reviewed for 205 consecutive patients with body mass indices (BMI) ≥ 30 kg/m
RESULTS RESULTS
The mean BMI was 36.9 ± 5.7 kg/m
CONCLUSIONS CONCLUSIONS
IAB is highly prevalent in patients with obesity and AF. Partial IAB, defined as PWD ≥ 120 ms, and advanced IAB with evidence of biphasic P-wave in inferior leads were independently associated with increased risk of recurrent arrhythmia after AF ablation. Its predictive value is independent of other traditional risk factors, LAVI, or use of AADs.

Identifiants

pubmed: 36462063
doi: 10.1007/s10840-022-01439-y
pii: 10.1007/s10840-022-01439-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1391-1399

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Providência R, Adragão P, de Asmundis C, Chun J, Chierchia G, Defaye P, Anselme F, Creta A, Lambiase PD, Schmidt B, Chen S, Cavaco D, Hunter RJ, Carmo J, Combes S, Honarbakhsh S, Combes N, Sousa MJ, Jebberi Z, Albenque JP, Boveda S. Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: A European observational multicenter study. J Am Heart Assoc. 2019;8(20):e012253.
Bachmann G. The inter-auricular time interval. American Jof Physiol-Legacy Content. 1916;41:309–20.
doi: 10.1152/ajplegacy.1916.41.3.309
Ar J. Intra-atrial block: definition and relationship to atrial fibrillation and other adverse outcomes. J Atr Fibrillation. 2019;12:2234.
doi: 10.4022/jafib.2234
Bayés de Luna A, Platonov P, Cosio FG, et al. Interatrial blocks. A separate entity from left atrial enlargement: a consensus report. J Electrocardiol. 2012;45:445–51.
doi: 10.1016/j.jelectrocard.2012.06.029 pubmed: 22920783
Cosío FG, Martín-Peñato A, Pastor A, et al. Atrial activation mapping in sinus rhythm in the clinical electrophysiology laboratory: observations during Bachmann’s bundle block. J Cardiovasc Electrophysiol. 2004;15:524–31.
doi: 10.1046/j.1540-8167.2004.03403.x pubmed: 15149420
Waldo AL, Bush HL, Gelband H, Zorn GL, Vitikainen KJ, Hoffman BF. Effects on the canine P wave of discrete lesions in the specialized atrial tracts. Circ Res. 1971;29:452–67.
doi: 10.1161/01.RES.29.5.452 pubmed: 5120612
Alexander B, MacHaalany J, Lam B, et al. Comparison of the extent of coronary artery disease in patients with versus without interatrial block and implications for new-onset atrial fibrillation. Am J Cardiol. 2017;119:1162–5.
doi: 10.1016/j.amjcard.2016.12.032 pubmed: 28214506
Enriquez A, Conde D, Femenia F, et al. Relation of interatrial block to new-onset atrial fibrillation in patients with Chagas cardiomyopathy and implantable cardioverter-defibrillators. Am J Cardiol. 2014;113:1740–3.
doi: 10.1016/j.amjcard.2014.02.036 pubmed: 24698463
Caldwell JC, Koppikar S, Barake W, et al. Advanced interatrial block is associated with atrial fibrillation recurrence after successful pulmonary vein isolation for paroxysmal atrial fibrillation. J Electrocardiol. 2013;46: e1.
doi: 10.1016/j.jelectrocard.2013.05.010
Enriquez A, Conde D, Hopman W, et al. Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion. Cardiovasc Ther. 2014;32:52–6.
doi: 10.1111/1755-5922.12063 pubmed: 24417765
Alexander B, Milden J, Hazim B, et al. New electrocardiographic score for the prediction of atrial fibrillation: the MVP ECG risk score (morphology-voltage-P-wave duration). Ann Noninvasive Electrocardiol. 2019;24:e12669.
doi: 10.1111/anec.12669 pubmed: 31184409 pmcid: 6931412
Huang Z, Zheng Z, Wu B, et al. Predictive value of P wave terminal force in lead V1 for atrial fibrillation: a meta-analysis. Ann Noninvasive Electrocardiol. 2020;25:e12739–e12739.
doi: 10.1111/anec.12739 pubmed: 32022368 pmcid: 7358887
Bayés de Luna A, Baranchuk A, Alberto Escobar Robledo L, Massó van Roessel A, Martínez-Sellés M. Diagnosis of interatrial block. J Geriatr Cardiol. 2017;14(3):161–5.
pubmed: 28592957 pmcid: 5460060
Szilágyi J, Walters TE, Marcus GM, et al. Surface ECG and intracardiac spectral measures predict atrial fibrillation recurrence after catheter ablation. J Cardiovasc Electrophysiol. 2018;29:1371–8.
doi: 10.1111/jce.13699 pubmed: 30016007
Park JK, Park J, Uhm JS, Joung B, Lee MH, Pak HN. Low P-wave amplitude (<0.1 Mv) in lead I is associated with displaced inter-atrial conduction and clinical recurrence of paroxysmal atrial fibrillation after radiofrequency catheter ablation. Europace. 2016;18:384–91.
doi: 10.1093/europace/euv028 pubmed: 25969437
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal - Cardiovascular Imaging. 2015;16:233–71.
doi: 10.1093/ehjci/jev014 pubmed: 25712077
Huxley RR, Lopez FL, Folsom AR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:1501–8.
doi: 10.1161/CIRCULATIONAHA.110.009035 pubmed: 21444879 pmcid: 3181498
Mahajan R, Lau DH, Brooks AG, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol. 2015;66:1–11.
doi: 10.1016/j.jacc.2015.04.058 pubmed: 26139051
Schram-Serban C, Heida A, Roos-Serote MC, Knops P, Kik C, Brundel B, Bogers AJJC, de Groot NMS. Heterogeneity in conduction underlies obesity-related atrial fibrillation vulnerability. Circ Arrhythm Electrophysiol. 2020;13(5):e008161.
Auricchio A, Özkartal T, Salghetti F, et al. Short P-wave duration is a marker of higher rate of atrial fibrillation recurrences after pulmonary vein isolation: new insights into the pathophysiological mechanisms through computer simulations. J Am Heart Assoc. 2021;10: e018572.
doi: 10.1161/JAHA.120.018572 pubmed: 33410337 pmcid: 7955300
Yagmur J, Cansel M, Acikgoz N, et al. Assessment of atrial electromechanical delay by tissue Doppler echocardiography in obese subjects. Obesity. 2011;19:779–83.
doi: 10.1038/oby.2010.195 pubmed: 20829801
Etemad T, Hosseinsabet A. Determinants of left intra-atrial electromechanical delay as evaluated by tissue Doppler imaging in candidates for coronary artery bypass graft surgery. Echocardiography. 2020;37:260–9.
doi: 10.1111/echo.14599 pubmed: 32003911
Chen LY, Ribeiro ALP, Platonov PG, Cygankiewicz I, Soliman EZ, Gorenek B, Ikeda T, Vassilikos VP, Steinberg JS, Varma N, Bayés-de-Luna A, Baranchuk A. P wave parameters and indices: A critical appraisal of clinical utility, challenges, and future research: A consensus document endorsed by the international society of electrocardiology and the international society for holter and noninvasive electrocardiology. Circ Arrhythmia Electrophysiol. 2022;15(4):e010435.
Martínez-Sellés M, Elosua R, Ibarrola M, et al. Advanced interatrial block and P-wave duration are associated with atrial fibrillation and stroke in older adults with heart disease: the BAYES registry. EP Europace. 2020;22:1001–8.
doi: 10.1093/europace/euaa114 pubmed: 32449904

Auteurs

Hannah K Tandon (HK)

Department of Internal Medicine, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239-3098, USA.

Kara Stout (K)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

David T Shin (DT)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Muaaz Almerstani (M)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Ahmad Aroudaky (A)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Jason P Payne (JP)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Neha Goyal (N)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Shane F Tsai (SF)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Arthur Easley (A)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Faris Khan (F)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

John R Windle (JR)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Daniel R Anderson (DR)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

John William Schleifer (JW)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA.

Niyada Naksuk (N)

Division of Cardiovascular Medicine, University of Nebraska Medical Center, 9882265 Nebraska Medical Center, Omaha, NE, 68198-2265, USA. niyada.naksuk@unmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH